1st Quarter - Report

CROSSROADS STRATEGIES, LLC for EISAI, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Regulatory and legislative health care issues, including: Alzheimer's drug development; Drug Pricing; H.R.5378, Lower Costs, More Transparency Act; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; S.3430, Better Mental Health Care Lower-Cost Drugs and Health Extenders Act; S.2973, Modernizing and Ensuring PBM Accountability Act; H.R.2882, Further Consolidated Appropriations Act, 2024, P.L.118-47.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5378 (118th), S. 2973 (118th), H.R. 2882 (118th), S. 3430 (118th)

Medicare/Medicaid MMM

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Drug Pricing; CMS NCD for Alzheimer's Drugs; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation; CMMI Proposed Accelerated Approval Payment Policy; CMMI Medicaid Proposed Rebate Rule.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5376 (118th)

Taxation/Internal Revenue Code TAX

Issues related to R&D tax credit; H.R.7024, Tax Relief for American Families and Workers Act of 2024.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7024 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.